Core Laboratories Inc. (CLB) stock
Close on Nov 13, 2026Market cap $417.45MP/E 26.8Yield 0.44%
Earnings
Core Laboratories's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Core Laboratories's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 3, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Oct 28, 2026after the close | $132.10M | -1.8% | $0.12 | $0.16 | Release |
| Q2 FY2026ended Jun 30, 2026 | Jul 29, 2026after the close | $124.60M | -4.3% | $0.13 | $0.11 | Release |
| Q1 FY2026ended Mar 31, 2026 | Apr 29, 2026after the close | $121.80M | -1.5% | -$0.02 | $0.06 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 4, 2026after the close | $138.30M | +7.0% | $0.15 | $0.21 | Release |
| Q3 FY2025ended Sep 30, 2025 | Oct 22, 2025after the close | $134.50M | +0.1% | $0.30 | $0.22 | Release |
| Q2 FY2025ended Jun 30, 2025 | Jul 23, 2025after the close | $130.20M | -0.3% | $0.22 | $0.19 | Release |
| Q1 FY2025ended Mar 31, 2025 | Apr 23, 2025after the close | $123.60M | -4.6% | $0.00 | $0.14 | Release |
| Q4 FY2024ended Dec 31, 2024 | Jan 29, 2025after the close | $129.20M | +0.8% | $0.15 | $0.22 | Release |
| Q3 FY2024ended Sep 30, 2024 | Oct 23, 2024after the close | $134.40M | +7.3% | $0.25 | $0.25 | Release |
| Q2 FY2024ended Jun 30, 2024 | Jul 24, 2024after the close | $130.60M | +2.1% | $0.19 | $0.22 | Release |
| Q1 FY2024ended Mar 31, 2024 | Apr 24, 2024after the close | $129.60M | – | $0.07 | $0.19 | Release |
| Q4 FY2023ended Dec 31, 2023 | Jan 31, 2024after the close | $128.20M | – | $0.14 | $0.19 | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 1, 2023after the close | $125.30M | – | $0.19 | $0.22 | Release |
| Q2 FY2023ended Jun 30, 2023 | Jul 26, 2023after the close | $127.90M | – | $0.48 | $0.21 | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Core Laboratories's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| revenuenon-GAAP | Q4 FY2026 | $128.50M – $134.50M | – | New | Oct 28, 2026 |
| operating incomenon-GAAP | Q4 FY2026 | $10.70M – $15.10M | – | New | Oct 28, 2026 |
| operating marginsnon-GAAP | Q4 FY2026 | 10% | – | New | Oct 28, 2026 |
| EPSnon-GAAP | Q4 FY2026 | $0.12 – $0.20 | – | New | Oct 28, 2026 |
Guidance vs results
The last range Core Laboratories gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q3 FY2026 | Revenue | $81.00M – $84.00M | $132.10M | Above range |
| Q2 FY2026 | EPS | $0.06 – $0.12 | $0.11 | Within range |
| Q2 FY2026 | Revenue | $77.50M – $82.50M | $124.60M | Above range |
| Q1 FY2026 | EPS | $0.11 – $0.15 | $0.06 | Below range |
| Q1 FY2026 | Revenue | $82.00M – $86.00M | $121.80M | Above range |
| Q4 FY2025 | EPS (GAAP) | $0.18 – $0.22 | $0.15 | Below range |
| Q4 FY2025 | Revenue | $88.00M – $90.00M | $138.30M | Above range |
| Q3 FY2025 | EPS | $0.18 – $0.22 | $0.22 | Within range |
| Q3 FY2025 | Revenue | $127.50M – $134.50M | $134.50M | Within range |
| Q2 FY2025 | EPS | $0.17 – $0.21 | $0.19 | Within range |
| Q2 FY2025 | Revenue | $85.00M – $89.00M | $130.20M | Above range |
| Q1 FY2025 | EPS (GAAP) | $0.12 – $0.16 | $0.00 | Below range |
| Q1 FY2025 | Revenue | $82.00M – $85.00M | $123.60M | Above range |
| Q4 FY2024 | Revenue | $87.50M – $90.50M | $129.20M | Above range |
| Q3 FY2024 | EPS | $0.23 – $0.27 | $0.25 | Within range |
| Q3 FY2024 | Revenue | $131.00M – $137.00M | $134.40M | Within range |
| Q2 FY2024 | EPS | $0.19 – $0.23 | $0.22 | Within range |
| Q2 FY2024 | Revenue | $130.00M – $136.00M | $130.60M | Within range |
| Q1 FY2024 | EPS | $0.14 – $0.18 | $0.19 | Above range |
| Q1 FY2024 | Revenue | $122.00M – $128.00M | $129.60M | Above range |
| Q4 FY2023 | EPS | $0.17 – $0.23 | $0.19 | Within range |
| Q4 FY2023 | Revenue | $125.00M – $132.00M | $128.20M | Within range |
| Q3 FY2023 | EPS | $0.21 – $0.25 | $0.22 | Within range |
| Q3 FY2023 | Revenue | $128.00M – $132.00M | $125.30M | Below range |
Guidance history
Every forecast Core Laboratories put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Oct 28, 2026 | EPS | Q4 FY2026 | $0.12 – $0.20 | New |
| Oct 28, 2026 | operating income | Q4 FY2026 | $10.70M – $15.10M | New |
| Oct 28, 2026 | operating margins | Q4 FY2026 | 10% | New |
| Oct 28, 2026 | revenue | Q4 FY2026 | $128.50M – $134.50M | New |
| Jul 29, 2026 | operating income | Q3 FY2026 | $5.50M – $7.90M | New |
| Jul 29, 2026 | operating income | Q3 FY2026 | $4.80M – $6.90M | Lowered |
| Jul 29, 2026 | operating income | Q3 FY2026 | $10.50M – $15.00M | Raised |
| Jul 29, 2026 | operating margins | Q3 FY2026 | 10% | New |
| Jul 29, 2026 | EPS | Q3 FY2026 | $0.12 – $0.20 | New |
| Jul 29, 2026 | Reservoir Description’s third quarter 2026 revenue | Q3 FY2026 | $81.00M – $84.00M | New |
| Jul 29, 2026 | Production Enhancement’s third quarter revenue | Q3 FY2026 | $47.50M – $51.50M | Lowered |
| Jul 29, 2026 | Core’s third quarter 2026 revenue | Q3 FY2026 | $128.50M – $135.50M | Raised |
| Apr 29, 2026 | EPS | Q2 FY2026 | $0.06 – $0.12 | New |
| Apr 29, 2026 | operating income | Q2 FY2026 | $3.50M – $5.38M | New |
| Apr 29, 2026 | operating income | Q2 FY2026 | $2.80M – $4.70M | Lowered |
| Apr 29, 2026 | operating income | Q2 FY2026 | $6.40M – $10.20M | Raised |
| Apr 29, 2026 | operating margins | Q2 FY2026 | 7% | New |
| Apr 29, 2026 | Reservoir Description’s second quarter 2026 revenue | Q2 FY2026 | $77.50M – $82.50M | New |
| Apr 29, 2026 | Production Enhancement’s second quarter revenue | Q2 FY2026 | $45.50M – $48.50M | Lowered |
| Apr 29, 2026 | Core’s second quarter 2026 revenue | Q2 FY2026 | $123.00M – $131.00M | Raised |
| Feb 4, 2026 | EPS | Q1 FY2026 | $0.11 – $0.15 | New |
| Feb 4, 2026 | Reservoir Description operating income | Q1 FY2026 | $6.80M – $8.25M | New |
| Feb 4, 2026 | Production Enhancement operating income | Q1 FY2026 | $2.80M – $3.80M | Lowered |
| Feb 4, 2026 | operating income | Q1 FY2026 | $9.70M – $12.20M | Raised |
| Feb 4, 2026 | operating margins | Q1 FY2026 | 9% | New |
| Feb 4, 2026 | Reservoir Description revenue | Q1 FY2026 | $82.00M – $86.00M | New |
| Feb 4, 2026 | Production Enhancement revenue | Q1 FY2026 | $42.00M – $44.00M | Lowered |
| Feb 4, 2026 | revenue | Q1 FY2026 | $124.00M – $130.00M | Raised |
| Oct 22, 2025 | EPS | Q4 FY2025 | $0.18 – $0.22 | New |
| Oct 22, 2025 | operating income | Q4 FY2025 | $11.00M – $12.30M | New |
| Oct 22, 2025 | operating income | Q4 FY2025 | $2.90M – $3.70M | Lowered |
| Oct 22, 2025 | operating income | Q4 FY2025 | $14.00M – $16.10M | Raised |
| Oct 22, 2025 | operating margins | Q4 FY2025 | 11% | New |
| Oct 22, 2025 | Reservoir Description’s fourth quarter revenue | Q4 FY2025 | $88.00M – $90.00M | New |
| Oct 22, 2025 | Production Enhancement’s fourth quarter revenue | Q4 FY2025 | $44.00M – $46.00M | Lowered |
| Oct 22, 2025 | fourth quarter 2025 revenue | Q4 FY2025 | $132.00M – $136.00M | Raised |
| Jul 23, 2025 | EPS | Q3 FY2025 | $0.18 – $0.22 | New |
| Jul 23, 2025 | operating income | Q3 FY2025 | $13.60M – $16.20M | New |
| Jul 23, 2025 | operating margins | Q3 FY2025 | 11% | New |
| Jul 23, 2025 | revenue | Q3 FY2025 | $127.50M – $134.50M | New |
| Apr 23, 2025 | EPS | Q2 FY2025 | $0.17 – $0.21 | New |
| Apr 23, 2025 | operating income | Q2 FY2025 | $11.00M – $13.00M | New |
| Apr 23, 2025 | operating income | Q2 FY2025 | $2.00M – $2.60M | Lowered |
| Apr 23, 2025 | operating income | Q2 FY2025 | $13.10M – $15.70M | Raised |
| Apr 23, 2025 | operating margins | Q2 FY2025 | 11% | New |
| Apr 23, 2025 | effective tax rate | Q2 FY2025 | 25% | New |
| Apr 23, 2025 | effective tax rate | FY2025 | 25% | New |
| Apr 23, 2025 | revenue | Q2 FY2025 | $85.00M – $89.00M | New |
| Apr 23, 2025 | revenue | Q2 FY2025 | $43.00M – $45.00M | Lowered |
| Apr 23, 2025 | revenue | Q2 FY2025 | $128.00M – $134.00M | Raised |
| Jan 29, 2025 | EPS | Q1 FY2025 | $0.12 – $0.16 | New |
| Jan 29, 2025 | operating income | Q1 FY2025 | $9.00M – $10.70M | New |
| Jan 29, 2025 | operating income | Q1 FY2025 | $1.10M – $2.00M | Lowered |
| Jan 29, 2025 | operating income | Q1 FY2025 | $10.20M – $12.80M | Raised |
| Jan 29, 2025 | operating margins | Q1 FY2025 | 9% | New |
| Jan 29, 2025 | effective tax | FY2025 | 25% | New |
| Jan 29, 2025 | Reservoir Description’s first quarter revenue | Q1 FY2025 | $82.00M – $85.00M | New |
| Jan 29, 2025 | Production Enhancement’s first quarter revenue | Q1 FY2025 | $39.00M – $42.00M | Lowered |
| Jan 29, 2025 | revenue | Q1 FY2025 | $121.00M – $127.00M | Raised |
| Oct 23, 2024 | operating income | Q4 FY2024 | $13.40M – $14.90M | New |
| Oct 23, 2024 | operating income | Q4 FY2024 | $1.30M – $2.70M | Lowered |
| Oct 23, 2024 | operating income | Q4 FY2024 | $14.80M – $17.70M | Raised |
| Oct 23, 2024 | operating margins | Q4 FY2024 | 12% | New |
| Oct 23, 2024 | effective tax rate | Q4 FY2024 | 20% | New |
| Oct 23, 2024 | EPS | Q4 FY2024 | $0.20 – $0.25 | New |
| Oct 23, 2024 | Reservoir Description revenue | Q4 FY2024 | $87.50M – $90.50M | New |
| Oct 23, 2024 | Production Enhancement segment revenue | Q4 FY2024 | $41.00M – $45.00M | Lowered |
| Oct 23, 2024 | revenue | Q4 FY2024 | $128.50M – $135.50M | Raised |
| Jul 24, 2024 | EPS | Q3 FY2024 | $0.23 – $0.27 | New |
| Jul 24, 2024 | operating income | Q3 FY2024 | $16.90M – $19.10M | New |
| Jul 24, 2024 | operating margins | Q3 FY2024 | 13% | New |
| Jul 24, 2024 | revenue | Q3 FY2024 | $131.00M – $137.00M | New |
| Apr 24, 2024 | EPS | Q2 FY2024 | $0.19 – $0.23 | New |
| Apr 24, 2024 | operating income | Q2 FY2024 | $14.50M – $17.30M | New |
| Apr 24, 2024 | operating margins | Q2 FY2024 | 12% | New |
| Apr 24, 2024 | revenue | Q2 FY2024 | $130.00M – $136.00M | New |
| Jan 31, 2024 | EPS | Q1 FY2024 | $0.14 – $0.18 | New |
| Jan 31, 2024 | operating margins | Q1 FY2024 | 10% | New |
| Jan 31, 2024 | revenue | Q1 FY2024 | $122.00M – $128.00M | New |
| Nov 1, 2023 | EPS | Q4 FY2023 | $0.17 – $0.23 | New |
| Nov 1, 2023 | operating income | Q4 FY2023 | $13.80M – $17.30M | New |
| Nov 1, 2023 | operating margins | Q4 FY2023 | 12% | New |
| Nov 1, 2023 | revenue | Q4 FY2023 | $125.00M – $132.00M | New |
| Jul 26, 2023 | EPS | Q3 FY2023 | $0.21 – $0.25 | New |
| Jul 26, 2023 | operating income | Q3 FY2023 | $15.20M – $17.50M | New |
| Jul 26, 2023 | operating margins | Q3 FY2023 | 13% | New |
| Jul 26, 2023 | effective tax rate | Q3 FY2023 | 20% | New |
| Jul 26, 2023 | revenue | Q3 FY2023 | $128.00M – $132.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Core Laboratories filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Update
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
See a number that looks wrong?